Pharmaceutical

NCQA Unveils 2025 Health Plan Ratings

11 Health Plans Earn Top 5-Star Rating WASHINGTON, D.C., 3683 / ACCESS Newswire / September 16, 2025 / The National Committee…

3 months ago

NCQA Unveils 2025 Health Plan Ratings

11 Health Plans Earn Top 5-Star Rating WASHINGTON, D.C., 3683 / ACCESS Newswire / September 16, 2025 / The National Committee…

3 months ago

As Fall Sports Season Begins, ZetrOZ Systems’ SAM Technology Helps Athletes Prevent Re-Injury

Sustained acoustic medicine helps athletes bridge that critical gap between recovery and performance by providing an advanced, non-invasive therapy proven…

3 months ago

As Fall Sports Season Begins, ZetrOZ Systems’ SAM Technology Helps Athletes Prevent Re-Injury

Sustained acoustic medicine helps athletes bridge that critical gap between recovery and performance by providing an advanced, non-invasive therapy proven…

3 months ago

As Fall Sports Season Begins, ZetrOZ Systems’ SAM Technology Helps Athletes Prevent Re-Injury

Sustained acoustic medicine helps athletes bridge that critical gap between recovery and performance by providing an advanced, non-invasive therapy proven…

3 months ago

High BMI FTM Top Surgery Without Limits: Dr. Javad Sajan Offers Inclusive, Life-Saving Gender-Affirming Top Surgery

The Best FTM Top Surgeon in the US is Dr. Javad Sajan at Allure Esthetic SEATTLE, WA / ACCESS Newswire…

3 months ago

Allure Magazine Honors Arcutis’ ZORYVE® (roflumilast) with Prestigious Best of Beauty Breakthrough Award

ZORYVE Allure Best of Beauty Product Image Allure Best of Beauty Breakthrough Award Winner ZORYVE (roflumilast) cream 0.15%; ZORYVE (roflumilast)…

3 months ago

Aspire Biopharma Announces Initial Production Order of Two Million Servings (100,000 20-packs) of BUZZ BOMB(TM) Pre-Workout Supplement

Part of New Contract Manufacturing Agreement with SupraNaturals to Secure Additional Production CapacitySupraNaturals is a leading private label manufacturer in…

3 months ago

Mipletamig Delivers 100% Remission Rate in Cohort 3 of RAINIER Trial for AML

No dose-limiting toxicities or cytokine release syndrome observed in RAINIER to date; mipletamig shows consistently favorable safety and tolerabilityTrial progressing…

3 months ago

Avel eCare Honors Telehealth Awareness Week with Theme “Powered by People”

SIOUX FALLS SD / ACCESS Newswire / September 16, 2025 / Avel eCare is proud to join healthcare organizations nationwide…

3 months ago